Objective: To elucidate whether the chronic consumption of dealcoholised red wine (DRW) (polyphenol-rich component) and/ or red wine (RW) improves vascular function in hypercholesterolaemic postmenopausal women. Design, subjects and intervention: A randomised parallel-arm study. Forty-five hypercholesterolaemic postmenopausal women were randomised into either water, DRW or RW group for 6 weeks following a 4 week washout. Fasting measures of central haemodynamic parameters, arterial wave reflection and endothelial nitric oxide were taken at 0 and 6 weeks. Setting: Clinic in the School of Public Health, Curtin University. Results: There were no significant between group differences in arterial stiffness as measured by augmentation index (AIx) and augmentation pressure (AP). However, a significant within group decrease in AIx (À9%, P ¼ 0.02) and AP (À12%, P ¼ 0.02) was observed following DRW consumption. No significant changes were observed in central haemodynamic parameters and endothelial nitric oxide levels following DRW and RW consumption, compared to water. Conclusions: Neither the chronic consumption of DRW nor RW improved markers of arterial stiffness, compared to control. However, the significant within group improvements in these indices following the consumption of DRW cannot be overlooked and warrant further investigation.
Introduction
Arteriosclerosis (stiffening of the arteries) is associated with increased cardiovascular disease (CVD) morbidity and mortality, and has been implicated in the development of atherosclerosis (Meredith et al., 1993; Kingwell and Gatzka, 2002; Gonzalez and Selwyn, 2003) . Therefore, therapeutic strategies, which are able to improve arterial stiffness, are required.
Epidemiological studies have described a strong inverse relationship between moderate red wine (RW) consumption and CVD (St Leger et al., 1979; Renaud et al., 1992) . The polyphenolic compounds present in RW are thought to explain the putative beneficial effects on CVD (Hertog et al., 1993) . However presently, the mechanisms by which RW polyphenols reduce CVD risk are uncertain and require elucidation through well-controlled clinical trials.
Studies in animals and humans have suggested that RW and RW polyphenols may improve lipid profiles, reduce platelet aggregation, reduce endothelial dysfunction and improve blood pressure; however, their effect on arterial stiffness remains to be further investigated (Goldberg et al., 1996; Diebolt et al., 2001; Wang et al., 2002; Ralay Ranaivo et al., 2004) . To date, one study has investigated the effects of RW polyphenols (7alcohol) on arterial stiffness (Mahmud and Feely, 2002) . However, this study focused on acute beverage consumption and results showed no effect with dealcoholised red wine (DRW) (polyphenol-rich component) consumption. We speculated that a single dose of RW polyphenols may be insufficient to achieve a concentration in tissue and plasma, which is biologically active and that chronic consumption of these compounds may be required to attenuate arterial stiffness. In support of our hypothesis, recent studies in humans have shown that chronic consumption of specific polyphenols called isoflavones significantly reduced arterial stiffness (Nestel et al., 1999; Teede et al., 2003) . Therefore, the aim of this study was to investigate the effect of chronic consumption of RW (with and without alcohol) on vascular function in hypercholesterolaemic, postmenopausal women.
Subjects and methods

Subjects
Forty-five moderately hypercholesterolaemic postmenopausal women, between the ages of 50 and 70 years, were recruited from the community. Subjects were screened for plasma cholesterol levels of X5.5 mmol/l and plasma triglyceride levels of o2 mmol/l. All subjects who met inclusion criteria underwent a medical examination. Exclusion criteria included hormone replacement therapy, lipidlowering medication, use of steroids and other agents that may influence lipid metabolism, use of warfarin, smoking, hyper-or hypothyroidism, diabetes mellitus, cardiovascular events within past 6 months, psychological unsuitability, major systemic diseases, gastrointestinal problems, proteinuria, liver and renal failure, apolipoprotein genotype (E2/E2 exclusion). All procedures were approved by the Ethics Committee of Curtin University and conformed to the Helsinki Declaration. Subjects provided written informed consent examination before participation in the study.
Experimental protocol
The study was a randomised parallel-arm design examining the effects of chronic consumption of RW polyphenols (7alcohol) on vascular function in moderately hypercholesterolaemic postmenopausal women. Forty-five subjects were randomised into either a water, DRW or RW drinking group. The number of subjects in each intervention group was: 16 in the water group, 15 in the DRW group and 14 in the RW group. One subject from the DRW and RW groups, respectively, dropped out of the intervention as they were unable to comply fully with the study protocol owing to changes in personal circumstances (holidays and festive occasions involving food and alcohol consumption beyond study stipulations).
Initially, subjects underwent a 4-week washout period where they were required to abstain from alcohol and RW consumption, monitor intake of polyphenolic-rich food as well as maintain their usual dietary intake and physical activity level. The maintenance of usual dietary intake over the course of the trial was monitored through the completion of 3-day food diaries at the start and finish of the study. Standardised meals, including all main meals and snacks, were provided for 2 days before each intervention day in order to limit potential interferences from the previous meal. Instructions on the correct consumption of the standard meals were given to the subjects by a dietitian and compliance was monitored. Compliance to beverage consumption was monitored regularly by the completion of food dairies and serum g-glutamyl transpeptidase (gGT) levels were measured at baseline and 6 weeks subsequent to beverage consumption. gGT is a liver enzyme, which is elevated in the presence of certain enzyme inducers such as alcohol and is therefore a useful compliance marker for alcohol consumption.
Subsequent to the initial 4-week washout, subjects arrived at Curtin University after a 10-12 h fast for the collection of baseline measurements. Following a mandatory rest period of approximately 30 min, subjects had their central blood pressures and vascular function assessed using the SphygmoCort (AtCor Medical, NSW, Australia), and fasting blood samples drawn for analysis of nitric oxide levels. The subjects were then randomised to a 6-week intervention period consisting of 400 ml of either water, DRW or RW (approximately 13% (v/v) alcohol B40 g), supplemented with their evening meal. Total polyphenol content between the DRW and RW was identical. Fasting measurements of central blood pressure and vascular function, as well as blood collection for NO levels, were repeated after 6 weeks of beverage consumption. Blood samples were immediately centrifuged at 3000 r.p.m. at 41C for 10 min and plasma was collected for the determination of nitric oxide concentrations.
Total polyphenol content in RW and DRW
The total polyphenols in a 2001 Cabernet Sauvignon (13% (v/v) alcohol, Ferngrove Vineyard Ltd, Frankland, Western Australia) was quantified using a colorimetric assay with Folin-Ciocalteau reagent according to the method published by the Association of Official Analytical Chemists (Helrick, 1990) . Polyphenols are estimated at a wavelength of 760 nm in relation to a standard curve for gallic acid. Total polyphenol content in both full-compliment RW and DRW was approximately 2.5 g/l. Therefore, a total of 1 g of RW polyphenols was consumed by subjects on a daily basis. The RW was 2 years old at the time of experimentation.
Dealcoholised wine preparation
Ethanol was removed from RW by rotary evaporation at o401C to approximately 50% of the original volume. The dealcoholised wine was then made to 400 ml with water, ensuring that the concentration of polyphenols was identical to that in the full-compliment RW. The colorimetric estimation total polyphenol concentration cannot exclude that some more labile polyphenols in RW, such as anthocyanins and catechins, may have been degraded during rotary evaporation.
Pulse-wave analysis
Pulse-wave analysis (PWA) was used to assess central haemodynamic parameters and arterial wave reflection using the SphygmoCort (AtCor Medical, NSW, Australia). Subjects remained in a recumbent position for a 30 min rest period, followed by the measurement of brachial artery blood pressure using a sphygmomanometer. PWA was obtained by applanation tonometry, which involves partial flattening of the radial artery with a high-fidelity micromanometer. Data were collected directly onto a portable microcomputer equipped with SphygoCor software (SphygmoCort, AtCor Medical, NSW, Australia), which allows online recording of the peripheral arterial waveforms. At least four measurements were taken at 1 min intervals by a single-trained technician. Peripheral waveforms were visually assessed to ensure reproducibility and homogeneity of each wave recorded. After sequential waveforms had been obtained, the integral software was used to generate an average peripheral waveform. The corresponding central aortic pressure and waveform was then derived using a validated mathematical transfer function (Chen et al., 1997 ) , and analysed further to determine the following aortic indices: (1) central haemodynamic parameters including central systolic blood pressure (SBP), central diastolic blood pressure (DBP), mean arterial blood pressure (MP), end-systolic pressure (ESP); and (2) parameters of wave reflection including augmentation index (AIx), central augmentation pressure (AP) and time to reflection (T R ). Aortic pulse pressure (PP) was calculated by subtracting central DBP for central SBP. Wave reflection is dependent on the elasticity of the arteries, the transmission velocity of the pulse wave and distance to the major reflecting site. Therefore, assessing the degree of wave reflection using AIx, AP and T R provides a surrogate marker of arterial stiffness and pulse wave velocity. The present study showed a within-observer variability (7s.d.) for replicate measurements taken at each visit of 8.4 (74.4) % for AIx, 6.1 (74.7) % for T R and 1.8 (71.1) % for MP. The within-observer variability of measurements taken on three separate occasions was 8.7 (75.8) % for AIx, 4.75 (73.7) % for T R and 5.1 (72.8) % for MP. 
Measurement of nitric oxide
Results
Subject characteristics
The clinical characteristics of subjects in the water, DRW and RW groups measured at baseline are shown in Table 1 . There were no significant group differences in age, anthropometric measurements and CVD risk factors. Furthermore, there were no significant baseline differences in markers of vascular function measured between the 3 groups.
Nutritional assessment
There were no significant differences in macronutrient intake by subjects at the start and finish of the intervention ( Table 2 ). There was no change in serum gGT levels in subjects consuming water and DRW, confirming that subjects in these groups abstained from alcohol consumption over the 6 week intervention period. In subjects consuming RW, as expected, a progressive rise in serum gGT (Po0.05) was observed over the 6 week period.
Changes in central aortic indices
The central aortic indices were measured at baseline and 6 weeks (Table 3) . There was no change in central heart rate following the consumption of DRW and RW. In addition, there was no association between central heart rate and height, and the change in AIx, AP and T R . The AIx and AP did not change significantly following the consumption of DRW and RW over 6 weeks, compared to water. However, a within group analysis revealed a significant decrease from baseline in AIx (À9%, P ¼ 0.02) and AP (À12%, P ¼ 0.02) 6 weeks subsequent to DRW consumption (Table 2) . No significant changes were observed in the time to reflection (T R ) following the consumption of DRW and RW, compared to water (Table 2) .
Changes in central haemodynamic parameters
Central systolic pressure did not change significantly following the consumption of DRW and RW, compared to water (Table 3) . However, a nonsignificant downward trend in central SBP was observed after 6 weeks of DRW consumption (P ¼ 0.20). A significant positive correlation was observed between the change in central SBP from baseline to 6 weeks and the change in AIx (r ¼ 0.493, Po0.05), as well as the change in AP (r ¼ 0.748, Po0.001) following DRW consumption. Central DBP, PP, ESP and MP did not change significantly with DRW or RW consumption, compared to control, even when corrected for final body weight (Table 3) .
Changes in nitric oxide levels
The plasma nitric oxide levels were measured at baseline and 6 weeks (Table 3 ). There was no significant change in plasma nitric oxide levels following 6 weeks of DRW and RW consumption, compared to water. Data represents the mean (s.e.m.) of parameters associated with vascular function at baseline and 6 weeks following the consumption of water, DRW and RW. Statistically significant differences within groups are indicated by *Po0.05. % Aix ¼ augmentation index; AP ¼ augmentation pressure; T R ¼ time to reflection; HR ¼ heart rate; SBP ¼ systolic blood pressure; DBP ¼ diastolic blood pressure; PP ¼ pulse pressure; MP ¼ mean pressure; ESP ¼ end-systolic pressure; NO ¼ nitric oxide.
Discussion
Arteriosclerosis and other haemodynamic abnormalities in the vasculature bed contribute to an increase in CVD risk (Kingwell and Gatzka, 2002; Sato et al., 2005) . In the present study, neither the chronic consumption of DRW nor RW significantly improved markers of arterial stiffness and other central haemodynamic factors, compared to control, in hypercholesterolaemic postmenopausal women. However, the significant within group improvements observed in several markers of arterial stiffness following DRW consumption cannot be overlooked and warrant further investigation. Increased stiffness of the large arteries, including the aorta and its major branches, results in earlier pulse wave reflection from the periphery, which augments aortic SBP and PP, and leads to a subsequent increase in cardiac workload and reduced coronary perfusion (O'Rourke, 1990) . The increase in SBP owing to wave reflection is referred to as augmentation and is an indirect measure of arterial stiffness. The augmentation index has been shown to be an independent predictor of CVD mortality (Laurent et al., 2001; Boutouyrie et al., 2002; Nurnberger et al., 2002; Yufu et al., 2004) . Normal, age-specific, references ranges for AIx and other markers of arterial stiffness are yet to be established. However, in a cross-sectional study of 216 patients with and without atherosclerosis, Nurnberger et al. (2002) reported the mean (7s.e.m.) of various haemodynamic parameters of the entire population according to age cohorts. The population mean for AIx of subjects aged 50-59 years was 2372.6%. In comparison, our group of hypercholesterolaemic postmenopausal women collectively displayed a mean AIx of 3471.1%, suggesting enhanced arterial stiffness in this group.
Currently, clinical trials investigating the effect of RW and its polyphenolic constituents on arterial stiffness are limited to the effect of acute consumption in healthy volunteers (Mahmud and Feely, 2002) . In this study, we investigate, for the first time, the effect of chronic consumption of RW (7alcohol) on markers of arterial stiffness in hypercholesterolaemic postmenopausal women. Although no significant beverage effects in AIx and AP were observed, compared to control, the significant decrease in these indices from baseline levels following DRW consumption suggests a tendency for improvement in arterial stiffness. These effects may be partly due to the polyphenol component present in RW. However, the lack of overall treatment effects implies that the study may be underpowered to detect changes. Only limited studies have investigated the effect of food/nutrient components on arterial stiffness making estimations of an appropriate sample size difficult. Future studies investigating the effect of RW polyphenols on vascular parameters should consider a larger target group.
The precise mechanisms involved in the reduction of arterial stiffness observed with polyphenol consumption are uncertain. Increased angiotensin II activity has been shown to be a significant determinant of arterial stiffness and successful reduction of this enzyme has been demonstrated following polyphenol consumption in vivo (Benetos et al., 1996; Aviram and Dornfeld, 2001) . Furthermore, recent studies have suggested a strong cause/effect relationship between endothelial-derived NO and arterial stiffness (Wilkinson et al., 2002; Nigam et al., 2003) . Although stiffening of the central arteries is mainly dependent on structural changes within the vessel wall associated with ageing and other CV risk factors, changes in vasomotor tone are also partly responsible for arterial stiffening, as the large conduit arteries include an extensive muscular component. Therefore, arterial stiffness may to some extent be regulated by endothelial release of vasoactive substances such as NO. The results of our study showed no change in plasma NO levels following DRW and RW consumption, therefore do not support an interaction between arterial stiffness and NOmediated vasorelaxation. However, in vitro studies have demonstrated that certain RW polyphenols may also induce vasorelaxation by inhibition smooth muscle phosphodiesterases (Dell'Agli et al., 2005) . Furthermore, improvements in inflammatory markers such as C-reactive protein and inhibition of the vasoactive peptide, endothelin À1 have been associated with improvements arterial stiffness (McEniery et al., 2003; Kampus et al., 2004; Pirro et al., 2004) . Studies have shown that RW and RW polyphenols significantly reduce serum levels of C-reactive protein and strongly inhibits endothelin-1 synthesis, which may explain improvements in arterial stiffness (Corder et al., 2001; Khan et al., 2002; Estruch et al., 2004) .
Elevated systolic blood pressure has been identified as independent risk factors for CVD and are associated with enhanced end-systolic stress, increased cardiac hypertrophy, increased oxygen demand of the myocardium and alterations in vascular function (Borghi et al., 2003) . The major determinants of SBP are the pattern of left ventricular (LV) ejection, peripheral pulse wave reflection and arterial stiffness. As LV ejection remains relatively stable with age, changes in arterial stiffness will primarily modify SBP. Interestingly, the within-group decrease in AIx following DRW consumption was significantly correlated with a nonsignificant downward trend in central SBP, suggesting that the reduction from baseline in arterial stiffness may be responsible for the change in aortic SBP. The hypotensive effects of polyphenols have also been associated with enhanced endothelium-dependent vasorelaxation, inhibition of vasoconstriction induced by noradrenalin (Chen and Pace-Asciak, 1996; Bernatova et al., 2002) and inhibition of angiotensin converting enzyme (ACE) activity (Aviram and Dornfeld, 2001 ).
In conclusion, chronic consumption of DRW and RW showed no significant changes in vascular function compared to a control group in hypercholesterolaemic postmenopausal women. However, significant within group changes in markers of arterial stiffness were observed following DRW consumption suggesting a tendency for improvement in vascular function. Further studies investigating the dose dependent effects of chronic consumption of RW and its polyphenolic constituents in larger population groups are required. Elucidation of the effect of RW polyphenols on vascular function may provide potential mechanisms by which these compounds attenuate CVD risk.
